Trexquant Investment’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.92M Sell
364,455
-129,980
-26% -$2.33M 0.04% 626
2026
Q2
$7.75M Buy
494,435
+252,834
+105% +$3.01M 0.05% 544
2026
Q1
$2.42M Buy
241,601
+125,840
+109% +$1.86M 0.02% 922
2025
Q4
$3.53M Buy
+115,761
New +$3.09M 0.03% 754

Other funds holding BBNX

Trexquant Investment's BBNX Position: Q3 2026 in Review

Trexquant Investment reduced its Beta Bionics (BBNX) stake by 26% in Q3 2026, selling an estimated $2.33M and leaving 364,455 shares worth $6.92M. The position accounts for 0.04% of the portfolio, ranked #626.

Trexquant Investment first reported a position in BBNX in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.75M in Q2 2026. 153 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Trexquant Investment held 364,455 shares of Beta Bionics worth $6.92M as of Q3 2026.
  • Trexquant Investment sold 129,980 Beta Bionics shares in Q3 2026, an estimated $2.33M.
  • Beta Bionics made up 0.04% of Trexquant Investment's portfolio in Q3 2026, its #626 holding.
  • Trexquant Investment first reported a position in Beta Bionics in Q4 2025 and has held it in 4 quarters since.
  • Trexquant Investment's Beta Bionics position peaked at $7.75M in Q2 2026.
  • 153 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.